通过CT指导的臭氧介导脏缩改善了对抗性高血压患者的家庭血压控制
Yizhi Zhang1, Fang Zeng2, Bin Huang2
1Department of Cardiology, Guangzhou Red Cross Hospital, Jinan University; Department of Cardiology, Shanghai Renji Hospital, Shanghai Jiao Tong University.
Journal of visualized experiments : JoVE
|June 23, 2025
概括
通过CT指导的臭氧介导的同情性缩 (RDN) 为耐性高血压提供了有效的替代方案. 这种简化,无对比的技术显示出有希望的家庭血压控制没有并发症.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 心血管医学 心血管医学
- 干预性放射学 干预性放射学
背景情况:
- 同情性缩 (RDN) 越来越多地被认为具有降血压 (BP) 的作用.
- 目前以导管为基础的RDN方法具有实际的局限性.
- 对于抗性高血压 (RH) 管理,需要使用替代的RDN技术.
研究的目的:
- 评估CT导向臭氧介导RDN在控制RH患者的家庭血压中的有效性.
- 评估这种新型RDN方法的安全性和可行性.
主要方法:
- 一组15名RH患者接受了CT指导的臭氧介导RDN.
- 家庭血压受到监测,治疗后对抗高血压药物的使用进行了调整.
- 该技术涉及单边的,无对比的动脉干预.
主要成果:
- 观察到显著的家庭血压控制率:整体队列达到60.0%/93.3% (4周) 到80.0%/100% (12周) 的静脉/透气血压<140/90 mmHg.
- 具有正常基线功能的患者表现出更高的对照率 (57.1%/90.9%在第4周到90.9%/100%在第12周).
- 33.3%的患者达到最佳的上午血压目标 (≤135/85 mmHg);没有报告的手术内或手术后并发症.
结论:
- 通过CT指导的臭氧介导的RDN是一种安全有效的替代方案,用于管理耐性高血压.
- 简化,单方面,无对比的技术显示了显著的家庭BP降低.
- 这种方法可以避免动脉损伤,为RH治疗提供了一个有前途的选择.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
524
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
524
01:30Heart Failure V: Medical Management
34
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
34
01:16Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
327
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
327
01:28Hypertension IV: Drug Therapy and Lifestyle Modifications
54
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
54
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
228
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
228
01:25Antihypertensive Drugs: Direct Renin Inhibitors
849
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
849